Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2011 to 2025 of 8314 results

  1. Bioinductive collagen scaffold (Regeneten) for rotator cuf repair

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Intradiscal Platelet Rich Plasma (PRP) Injections for Back Pain with Modic Type 1 Changes

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. Cardiac ablation with percutaneous left atrial appendage occlusion (LAAO) for atrial fibrillation

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Digital tools and platforms to support the early detection and initial diagnosis of hearing loss

    Awaiting development Reference number: GID-HTE10088 Expected publication date: TBC

    Health technology evaluations
    Awaiting development

  6. Epilepsies in children, young people and adults

    In development Reference number: GID-NG10453 Expected publication date: TBC

    NICE guideline
    In development

  7. Retatrutide for managing overweight and obesity [ID6644]

    Awaiting development Reference number: GID-TA11845 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  8. Digital flexor tenotomy for diabetic foot

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  9. Durvalumab with bevacizumab and transarterial chemoembolisation for treating locally advanced hepatocellular carcinoma [ID3944]

    Awaiting development Reference number: GID-TA10911 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Datopotamab deruxtecan for previously treated hormone receptor-positive HER2-negative unresectable or metastatic breast cancer [ID6348]

    In development Reference number: GID-TA11402 Expected publication date: TBC

    Technology appraisal guidance
    In development

  11. Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  12. Nemolizumab for treating prurigo nodularis [ID6451]

    In development Reference number: GID-TA11566 Expected publication date: TBC

    Technology appraisal guidance
    In development

  13. Baloxavir marboxil for treating and preventing influenza in children 1 to 11 years [ID6554]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  14. DCVax-L for treating glioblastoma [ID836]

    In development Reference number: GID-TA10143 Expected publication date: TBC

    Technology appraisal guidance
    In development

  15. Secukinumab for treating giant cell arteritis in people 50 years and over [TSID12163]

    Awaiting development Reference number: GID-TA11761 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development